HJM-353: A potent, selective and orally bioavailable EED inhibitor with robust anti-tumor activities

Ma, X; Qi, W; Du, Y; Kong, D; Geng, Y; Zeng, L

ANNALS OF ONCOLOGY, 2022; 33 (7): S1122

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索